1
|
Paz MGOD, Bezerra MF, Mendes AF, da Silva A, Lima GBD, Gil LHVG, Pena LJ, Diniz GTN, Drexler JF, Oriá RB, Ferreira de Oliveira-Filho E, Reis CRDS. Development of a New Multispecies Protein A-Based ELISA for Serodiagnosis of Hepatitis E Infection with Validation in Domestic Swine. Foodborne Pathog Dis 2024. [PMID: 38708682 DOI: 10.1089/fpd.2023.0179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/07/2024] Open
Abstract
Hepatitis E virus (HEV) infects roughly 20 million people worldwide, causing self-limiting acute hepatic disease that can evolve into a chronic course. HEV-3, HEV-4, and HEV-7 genotypes are zoonotic and transmitted to humans by consuming raw or undercooked meat. Here, we developed an indirect ELISA based on the recombinant HEV-3 capsid and performed a seroprevalence study on domestic swine in northeastern Brazil. Our in-house ELISA was initially validated using a subset of 79 sera characterized by concordant results for two distinct commercial ELISA kits. Our ELISA exhibited excellent sensitivity (94%) and specificity (100%), with an area under the curve of 0.99 Further testing, including 212 swine sera, revealed a seroprevalence of 57.5% (95% confidence interval, 50.6-64.3%). Our findings indicate that the novel ELISA test could accurately detect specific anti-HEV antibodies in domestic pigs and should be further validated in humans and other mammals.
Collapse
Affiliation(s)
| | | | - Andrei Félix Mendes
- Department of Microbiology-Aggeu Magalhães Institute, Oswaldo Cruz Foundation, Recife, Brazil
| | - Adalucia da Silva
- Department of Microbiology-Aggeu Magalhães Institute, Oswaldo Cruz Foundation, Recife, Brazil
| | - Gustavo Barbosa de Lima
- Department of Microbiology-Aggeu Magalhães Institute, Oswaldo Cruz Foundation, Recife, Brazil
| | | | - Lindomar José Pena
- Department of Virology, Aggeu Magalhães Institute, Oswaldo Cruz Foundation, Recife, Brazil
| | - George Tadeu Nunes Diniz
- Statistics and Geoprocessing Center, Aggeu Magalhães Institute, Oswaldo Cruz Foundation, Recife, Brazil
| | - Jan Felix Drexler
- Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany
| | - Reinaldo Barreto Oriá
- Laboratory of the Biology of Tissue Healing, Ontogeny and Nutrition, Department of Morphology, Institute of Biomedicine, School of Medicine, Federal University of Ceará, Fortaleza, Brazil
| | - Edmilson Ferreira de Oliveira-Filho
- Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany
| | | |
Collapse
|
2
|
da Silva PG, Chaves EJF, Silva TMS, Rocha GB, Dantas WM, de Oliveira RN, Pena LJ. Antiviral Activity of Flavonoids from Geopropolis of the Brazilian Jandaira Bee against Zika and Dengue Viruses. Pharmaceutics 2023; 15:2494. [PMID: 37896254 PMCID: PMC10609720 DOI: 10.3390/pharmaceutics15102494] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2023] [Revised: 07/20/2023] [Accepted: 07/28/2023] [Indexed: 10/29/2023] Open
Abstract
Arthropod-borne viruses within the Flaviviridae family such as Zika (ZIKV) and dengue (DENV) are responsible for major outbreaks in tropical countries, and there are no specific treatments against them. Naringenin and 7-O-methyl naringenin are flavonoids that can be extracted from geopropolis, a natural material that the Brazilian Jandaira stingless bee (Melipona subnitida Ducke) produces to protect its nest. Here, these flavonoids were tested against ZIKV and DENV using Vero cells as a cellular model to perform a cytotoxicity assay and to define the effective concentrations of TCID50 as the readout method. The results demonstrated the antiviral activity of the compounds against both viruses upon the treatment of infected cells. The tested flavonoids had antiviral activity comparable with 6-methylmercaptopurine riboside (6-MMPr), used here as a positive control. In addition, to identify the possible action mechanism of the antiviral candidates, we carried out a docking analysis followed by a molecular dynamics simulation to elucidate naringenin and 7-O-methyl naringenin binding sites to each virus. Altogether, these results demonstrate that both flavonoids have potent antiviral effects against both viruses and warrant further in vivo trials.
Collapse
Affiliation(s)
- Poliana Gomes da Silva
- Laboratory of Virology and Experimental Therapy (Lavite), Department of Virology, Aggeu Magalhães Institute (IAM), Oswaldo Cruz Foundation (Fiocruz), Recife 50670-420, Pernambuco, Brazil; (P.G.d.S.); (E.J.F.C.); (W.M.D.)
| | - Elton José Ferreira Chaves
- Laboratory of Virology and Experimental Therapy (Lavite), Department of Virology, Aggeu Magalhães Institute (IAM), Oswaldo Cruz Foundation (Fiocruz), Recife 50670-420, Pernambuco, Brazil; (P.G.d.S.); (E.J.F.C.); (W.M.D.)
| | - Tania Maria Sarmento Silva
- Phytochemical Bioprospecting Laboratory, Department of Chemistry, Federal Rural University of Pernambuco, Recife 52171-900, Pernambuco, Brazil;
| | - Gerd Bruno Rocha
- Laboratory of Computational Quantum Chemistry, Department of Chemistry, Federal University of Paraiba, João Pessoa 58050-085, Paraiba, Brazil;
| | - Willyenne Marília Dantas
- Laboratory of Virology and Experimental Therapy (Lavite), Department of Virology, Aggeu Magalhães Institute (IAM), Oswaldo Cruz Foundation (Fiocruz), Recife 50670-420, Pernambuco, Brazil; (P.G.d.S.); (E.J.F.C.); (W.M.D.)
- Bioactive Compounds Synthesis Laboratory, Department of Chemistry, Federal Rural University of Pernambuco (UFRPE), Recife 52171-900, Pernambuco, Brazil;
| | - Ronaldo Nascimento de Oliveira
- Bioactive Compounds Synthesis Laboratory, Department of Chemistry, Federal Rural University of Pernambuco (UFRPE), Recife 52171-900, Pernambuco, Brazil;
| | - Lindomar José Pena
- Laboratory of Virology and Experimental Therapy (Lavite), Department of Virology, Aggeu Magalhães Institute (IAM), Oswaldo Cruz Foundation (Fiocruz), Recife 50670-420, Pernambuco, Brazil; (P.G.d.S.); (E.J.F.C.); (W.M.D.)
| |
Collapse
|
3
|
Landim MG, Carneiro MLB, Joanitti GA, Anflor CTM, Marinho DD, Rodrigues JFB, de Sousa WJB, Fernandes DDO, Souza BF, Ombredane AS, do Nascimento JCF, Felice GDJ, Kubota AMA, Barbosa JSC, Ohno JH, Amoah SKS, Pena LJ, Luz GVDS, de Andrade LR, Pinheiro WO, Ribeiro BM, Formiga FR, Fook MVL, Rosa MFF, Peixoto HM, Luiz Carregaro R, Rosa SDSRF. A novel N95 respirator with chitosan nanoparticles: mechanical, antiviral, microbiological and cytotoxicity evaluations. Discov Nano 2023; 18:118. [PMID: 37733165 PMCID: PMC10514013 DOI: 10.1186/s11671-023-03892-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/27/2023] [Accepted: 08/29/2023] [Indexed: 09/22/2023]
Abstract
BACKGROUND It is known that some sectors of hospitals have high bacteria and virus loads that can remain as aerosols in the air and represent a significant health threat for patients and mainly professionals that work in the place daily. Therefore, the need for a respirator able to improve the filtration barrier of N95 masks and even inactivating airborne virus and bacteria becomes apparent. Such a fact motivated the creation of a new N95 respirator which employs chitosan nanoparticles on its intermediate layer (SN95 + CNP). RESULTS The average chitosan nanoparticle size obtained was 165.20 ± 35.00 nm, with a polydispersity index of 0.36 ± 0.03 and a zeta potential of 47.50 ± 1.70 mV. Mechanical tests demonstrate that the SN95 + CNP respirator is more resistant and meets the safety requisites of aerosol penetration, resistance to breath and flammability, presenting higher potential to filtrate microbial and viral particles when compared to conventional SN95 respirators. Furthermore, biological in vitro tests on bacteria, fungi and mammalian cell lines (HaCat, Vero E6 and CCL-81) corroborate the hypothesis that our SN95 + CNP respirator presents strong antimicrobial activity and is safe for human use. There was a reduction of 96.83% of the alphacoronavirus virus and 99% of H1N1 virus and MHV-3 betacoronavirus after 120 min of contact compared to the conventional respirator (SN95), demonstrating that SN95 + CNP have a relevant potential as personal protection equipment. CONCLUSIONS Due to chitosan nanotechnology, our novel N95 respirator presents improved mechanical, antimicrobial and antiviral characteristics.
Collapse
Affiliation(s)
| | | | | | | | | | - José Filipe Bacalhau Rodrigues
- Northeast Laboratory for Evaluation and Development of Biomaterials (CERTBIO), University of Campina Grande, Campina Grande, Paraiba, Brazil
| | | | | | | | | | | | | | | | | | - John Hideki Ohno
- MCI Ultrasonica LTDA, Av. Campinas, 367 - Arraial Paulista, Taboão da Serra, São Paulo, Brazil
| | - Solomon Kweku Sagoe Amoah
- Northeast Laboratory for Evaluation and Development of Biomaterials (CERTBIO), University of Campina Grande, Campina Grande, Paraiba, Brazil
| | | | | | | | | | | | | | - Marcus Vinícius Lia Fook
- Northeast Laboratory for Evaluation and Development of Biomaterials (CERTBIO), University of Campina Grande, Campina Grande, Paraiba, Brazil
| | | | | | | | | |
Collapse
|
4
|
Rosa RB, de Castro EF, de Oliveira Santos D, da Silva MV, Pena LJ. Mouse Models of Mayaro Virus. Viruses 2023; 15:1803. [PMID: 37766210 PMCID: PMC10534528 DOI: 10.3390/v15091803] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2023] [Revised: 06/20/2023] [Accepted: 06/22/2023] [Indexed: 09/29/2023] Open
Abstract
Mayaro virus (MAYV), the etiologic agent of Mayaro fever, leads patients to severe myalgia and arthralgia, which can have a major impact on public health in all the countries where the virus circulates. The emergence and dissemination of new viruses have led the scientific community to develop new in vivo models that can help in the fight against new diseases. So far, mice have been the most used animal model in studies with MAYV and have proved to be an adequate model for recapitulating several aspects of the disease observed in humans. Mice are widely used in in vivo research and, therefore, are well known in the scientific community, which has allowed for different strains to be investigated in the study of MAYV. In this review, we summarize the main studies with MAYV using mice as an experimental model and discuss how they can contribute to the advancement of the understanding of its pathogenesis and the development of new drugs and vaccines.
Collapse
Affiliation(s)
- Rafael Borges Rosa
- Department of Virology and Experimental Therapy (LAVITE), Aggeu Magalhães Institute (IAM), Oswaldo Cruz Foundation (Fiocruz), Recife 50740-465, Brazil
- Rodents Animal Facilities Complex, Federal University of Uberlandia (REBIR-UFU), Uberlandia 38400-902, Brazil;
| | - Emilene Ferreira de Castro
- Faculty of Medicine, Federal University of Uberlandia, Uberlandia 38400-902, Brazil;
- Dental Hospital, Oral Pathology Laboratory, University of Uberlandia, Uberlandia 38400-902, Brazil;
| | | | - Murilo Vieira da Silva
- Rodents Animal Facilities Complex, Federal University of Uberlandia (REBIR-UFU), Uberlandia 38400-902, Brazil;
| | - Lindomar José Pena
- Department of Virology and Experimental Therapy (LAVITE), Aggeu Magalhães Institute (IAM), Oswaldo Cruz Foundation (Fiocruz), Recife 50740-465, Brazil
| |
Collapse
|
5
|
Silva AJD, de Jesus ALS, Leal LRS, de Macêdo LS, da Silva Barros BR, de Sousa GF, da Paz Leôncio Alves S, Pena LJ, de Melo CML, de Freitas AC. Whole Yeast Vaccine Displaying ZIKV B and T Cell Epitopes Induces Cellular Immune Responses in the Murine Model. Pharmaceutics 2023; 15:1898. [PMID: 37514084 PMCID: PMC10385271 DOI: 10.3390/pharmaceutics15071898] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2023] [Revised: 06/30/2023] [Accepted: 07/04/2023] [Indexed: 07/30/2023] Open
Abstract
Improving antigen presentation is crucial for the success of immunization strategies. Yeasts are classically used as biofactories to produce recombinant proteins and are efficient vehicles for antigen delivery, in addition to their adjuvant properties. Despite the absence of epidemic outbreaks, several vaccine approaches continue to be developed for Zika virus infection. The development of these prophylactic strategies is fundamental given the severity of clinical manifestations, mainly due to viral neurotropism. The present study aimed to evaluate in vivo the immune response induced by P. pastoris recombinant strains displaying epitopes of the envelope (ENV) and NS1 ZIKV proteins. Intramuscular immunization with heat-attenuated yeast enhanced the secretion of IL-6, TNF-α, and IFN-γ, in addition to the activation of CD4+ and CD8+ T cells, in BALB/c mice. P. pastoris displaying ENV epitopes induced a more robust immune response, increasing immunoglobulin production, especially IgG isotypes. Both proposed vaccines showed the potential to induce immune responses without adverse effects, confirming the safety of administering P. pastoris as a vaccine vehicle. Here, we demonstrated, for the first time, the evaluation of a vaccine against ZIKV based on a multiepitope construct using yeast as a delivery system and reinforcing the applicability of P. pastoris as a whole-cell vaccine.
Collapse
Affiliation(s)
- Anna Jéssica Duarte Silva
- Laboratory of Molecular Studies and Experimental Therapy-LEMTE, Department of Genetics, Federal University of Pernambuco, Recife 50670-901, Brazil
| | | | - Lígia Rosa Sales Leal
- Laboratory of Molecular Studies and Experimental Therapy-LEMTE, Department of Genetics, Federal University of Pernambuco, Recife 50670-901, Brazil
| | - Larissa Silva de Macêdo
- Laboratory of Molecular Studies and Experimental Therapy-LEMTE, Department of Genetics, Federal University of Pernambuco, Recife 50670-901, Brazil
| | | | | | | | - Lindomar José Pena
- Department of Virology and Experimental Therapy, Instituto Aggeu Magalhães, Oswaldo Cruz Foundation, Recife 50670-901, Brazil
| | | | - Antonio Carlos de Freitas
- Laboratory of Molecular Studies and Experimental Therapy-LEMTE, Department of Genetics, Federal University of Pernambuco, Recife 50670-901, Brazil
| |
Collapse
|
6
|
Dos Santos DRL, Durães-Carvalho R, Gardinali NR, Machado LC, de Paula VS, da Luz Wallau G, de Oliveira JM, Pena LJ, Pinto MA, Gil LHVG, de Oliveira-Filho EF. Uncovering neglected subtypes and zoonotic transmission of Hepatitis E virus (HEV) in Brazil. Virol J 2023; 20:83. [PMID: 37131237 PMCID: PMC10152778 DOI: 10.1186/s12985-023-02047-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2023] [Accepted: 04/22/2023] [Indexed: 05/04/2023] Open
Abstract
Hepatitis E virus (HEV) circulation in humans and swine has been extensively studied in South America over the last two decades. Nevertheless, only 2.1% of reported HEV strains are available as complete genome sequences. Therefore, many clinical, epidemiological, and evolutionary aspects of circulating HEV in the continent still need to be clarified. Here, we conducted a retrospective evolutionary analysis of one human case and six swine HEV strains previously reported in northeastern, southern, and southeastern Brazil. We obtained two complete and four nearly complete genomic sequences. Evolutionary analysis comparing the whole genomic and capsid gene sequences revealed high genetic variability. This included the circulation of at least one unrecognized unique South American subtype. Our results corroborate that sequencing the whole capsid gene could be used as an alternative for HEV subtype assignment in the absence of complete genomic sequences. Moreover, our results substantiate the evidence for zoonotic transmission by comparing a larger genomic fragment recovered from the sample of the autochthonous human hepatitis E case. Further studies should continuously investigate HEV genetic diversity and zoonotic transmission of HEV in South America.
Collapse
Affiliation(s)
- Debora Regina Lopes Dos Santos
- Department of Virology, Aggeu Magalhães Institute, Oswaldo Cruz Foundation (IAM- FIOCRUZ), Recife, Pernambuco, Brazil
- Veterinary Institute, Federal Rural University of Rio de Janeiro (UFRRJ), Seropédica, Rio de Janeiro, Brazil
| | - Ricardo Durães-Carvalho
- São Paulo School of Medicine, Department of Microbiology, Immunology and Parasitology, Federal University of São Paulo (UNIFESP), São Paulo, SP, Brazil
- Post-Graduate Program in Structural and Functional Biology, UNIFESP, São Paulo, Brazil
| | - Noemi Rovaris Gardinali
- Laboratório de Desenvolvimento Tecnológico em Virologia (LADTV) , Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil
- Laboratório de Tecnologia Virológica (LATEV) , Instituto de Tecnologia em Imunobiológicos (Biomanguinhos), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil
| | - Lais Ceschini Machado
- Department of Entomology and Bioinformatic Core, Oswaldo Cruz Foundation-Fiocruz, Recife, PE, Brazil
| | - Vanessa Salete de Paula
- Laboratory of Molecular Virology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation (IOC- FIOCRUZ), Rio de Janeiro, Brazil
| | - Gabriel da Luz Wallau
- Department of Entomology and Bioinformatic Core, Oswaldo Cruz Foundation-Fiocruz, Recife, PE, Brazil
- Department of Arbovirology, Bernhard Nocht Institute for Tropical Medicine, WHO Collaborating Center for Arbovirus and Hemorrhagic Fever Reference and Research, National Reference Center for Tropical Infectious Diseases, Bernhard-Nocht-Straße 74, 20359, Hamburg, Germany
| | - Jaqueline Mendes de Oliveira
- Laboratório de Desenvolvimento Tecnológico em Virologia (LADTV) , Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil
| | - Lindomar José Pena
- Department of Virology, Aggeu Magalhães Institute, Oswaldo Cruz Foundation (IAM- FIOCRUZ), Recife, Pernambuco, Brazil
| | - Marcelo Alves Pinto
- Laboratório de Desenvolvimento Tecnológico em Virologia (LADTV) , Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil
| | | | - Edmilson Ferreira de Oliveira-Filho
- Department of Virology, Aggeu Magalhães Institute, Oswaldo Cruz Foundation (IAM- FIOCRUZ), Recife, Pernambuco, Brazil.
- Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany.
| |
Collapse
|
7
|
Cassani NM, Santos IA, Grosche VR, Ferreira GM, Guevara-Vega M, Rosa RB, Pena LJ, Nicolau-Junior N, Cintra ACO, Mineo TP, Sabino-Silva R, Sampaio SV, Jardim ACG. Roles of Bothrops jararacussu toxins I and II: Antiviral findings against Zika virus. Int J Biol Macromol 2023; 227:630-640. [PMID: 36529220 DOI: 10.1016/j.ijbiomac.2022.12.102] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2022] [Revised: 12/09/2022] [Accepted: 12/10/2022] [Indexed: 12/16/2022]
Abstract
Zika virus is the etiologic agent of Zika fever, and has been previously associated with cases of microcephaly, drawing the attention of the health authorities worldwide. However, no vaccine or antiviral are currently available. Phospholipases A2 (PLA2) isolated from snake venoms have demonstrated antiviral activity against several viruses. Here we demonstrated the anti-ZIKV activity of bothropstoxins-I and II (BthTX-I and II) isolated from Bothrops jararacussu venom. Vero E6 cells were infected with ZIKVPE243 in the presence of compounds for 72 h, when virus titers were evaluated. BthTX-I and II presented strong dose-dependent inhibition of ZIKV, with a SI of 149.1 and 1.44 × 105, respectively. These toxins mainly inhibited the early stages of the replicative cycle, such as during the entry of ZIKV into host cells, as shown by the potent virucidal effect, suggesting the action of these toxins on the virus particles. Moreover, BthTX-I and II presented significant activity towards post-entry stages of the ZIKV replicative cycle. Molecular docking analyses showed that BthTX-I and II potentially interact with DII and DIII domains from ZIKV Envelope protein. Our findings show that these PLA2s could be used as useful templates for the development of future antiviral candidate drugs against Zika fever.
Collapse
Affiliation(s)
- Natasha Marques Cassani
- Institute of Biomedical Science (ICBIM), Federal University of Uberlândia (UFU), Uberlândia, Minas Gerais, Brazil
| | - Igor Andrade Santos
- Institute of Biomedical Science (ICBIM), Federal University of Uberlândia (UFU), Uberlândia, Minas Gerais, Brazil
| | - Victória Riquena Grosche
- Institute of Biomedical Science (ICBIM), Federal University of Uberlândia (UFU), Uberlândia, Minas Gerais, Brazil; Institute of Biosciences, Humanities and Exact Sciences (Ibilce), São Paulo State University (Unesp), São José do Rio Preto, SP, Brazil
| | - Giulia Magalhães Ferreira
- Institute of Biomedical Science (ICBIM), Federal University of Uberlândia (UFU), Uberlândia, Minas Gerais, Brazil
| | - Marco Guevara-Vega
- Institute of Biomedical Science (ICBIM), Federal University of Uberlândia (UFU), Uberlândia, Minas Gerais, Brazil
| | - Rafael Borges Rosa
- Rodents Animal Facilities Complex, Federal University of Uberlândia, Uberlândia, Minas Gerais, Brazil; Department of Virology, Aggeu Magalhães Institute (IAM), Oswaldo Cruz Foundation (Fiocruz), Recife, Brazil
| | - Lindomar José Pena
- Department of Virology, Aggeu Magalhães Institute (IAM), Oswaldo Cruz Foundation (Fiocruz), Recife, Brazil
| | - Nilson Nicolau-Junior
- Institute of Biotechnology, Federal University of Uberlândia (UFU), Uberlândia, Minas Gerais, Brazil
| | - Adélia Cristina Oliveira Cintra
- Department of Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo - USP, Ribeirão Preto, SP, Brazil
| | - Tiago Patriarca Mineo
- Institute of Biomedical Science (ICBIM), Federal University of Uberlândia (UFU), Uberlândia, Minas Gerais, Brazil
| | - Robinson Sabino-Silva
- Institute of Biomedical Science (ICBIM), Federal University of Uberlândia (UFU), Uberlândia, Minas Gerais, Brazil
| | - Suely Vilela Sampaio
- Department of Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo - USP, Ribeirão Preto, SP, Brazil
| | - Ana Carolina Gomes Jardim
- Institute of Biomedical Science (ICBIM), Federal University of Uberlândia (UFU), Uberlândia, Minas Gerais, Brazil; Institute of Biosciences, Humanities and Exact Sciences (Ibilce), São Paulo State University (Unesp), São José do Rio Preto, SP, Brazil.
| |
Collapse
|
8
|
de Moraes Gomes PAT, Barros Freitas LA, Pessoa Siqueira LR, da Conceição JM, Dos Santos IR, Pinto AF, de Melo Silva VG, Nunes JS, de Oliveira Cardoso MV, Pena LJ, Lima Leite AC. Identification of novel Zika virus inhibitors: a screening using thiosemicarbazones and thiazoles templates. Curr Top Med Chem 2022; 23:426-439. [PMID: 36567284 DOI: 10.2174/1568026623666221222124433] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2022] [Revised: 11/04/2022] [Accepted: 11/11/2022] [Indexed: 12/27/2022]
Abstract
BACKGROUND Zika virus (ZIKV) remains an important cause of congenital infection, fetal microcephaly, and Guillain-Barré syndrome in the population. In 2016, WHO declared a cluster of microcephaly cases and other neurological disorders reported as a global public health emergency in Brazil. There is still no specific treatment for Zika virus fever, only palliative care. Therefore, there is a need for new therapies against this disease. According to the literature, thiosemicarbazone, phthalimide and thiazole are privileged structures with several biological activities, including antiviral activity against various viruses. OBJECTIVE Based on this, this work presents an antiviral screening using previously synthesized compounds derived from thiosemicarbazone, phthalimide, and thiazole as new hits active against ZIKV. METHODS After synthesis and characterization, all compounds were submitted to Cytotoxicity by MTT and Antiviral activity against ZIKV assays. RESULTS Compounds 63, 64, 65, and 73 exhibited major reductions in the ZIKV title from this evaluation. Compounds 63 (99.74%), 64 (99.77%), 65 (99.92%), and 73 (99.21%) showed a higher inhibition than the standard 6MMPr (98.74%) at the CC20 dose. These results revealed new chemical entities with anti-ZIKV activity. CONCLUSION These derivatives are promising candidates for further assays. In addition, the current approach brings a new privileged scaffolding, which may drive future drug discovery for ZIKV.
Collapse
Affiliation(s)
- Paulo André Teixeira de Moraes Gomes
- Laboratory of Virology and Experimental Therapy; Federal University of Pernambuco, Brazil.,Laboratory of Medicinal Chemistry Planning, Department of Pharmaceutical Sciences, Health Sciences Center, Federal University of Pernambuco, Recife, PE, Brazil
| | - Luiz Alberto Barros Freitas
- Laboratory of Medicinal Chemistry Planning, Department of Pharmaceutical Sciences, Health Sciences Center, Federal University of Pernambuco, Recife, PE, Brazil
| | - Luciana Rabelo Pessoa Siqueira
- Laboratory of Medicinal Chemistry Planning, Department of Pharmaceutical Sciences, Health Sciences Center, Federal University of Pernambuco, Recife, PE, Brazil
| | - Juliana Maria da Conceição
- Laboratory of Medicinal Chemistry Planning, Department of Pharmaceutical Sciences, Health Sciences Center, Federal University of Pernambuco, Recife, PE, Brazil
| | - Ignes Regina Dos Santos
- Laboratory of Medicinal Chemistry Planning, Department of Pharmaceutical Sciences, Health Sciences Center, Federal University of Pernambuco, Recife, PE, Brazil
| | - Aline Ferreira Pinto
- Laboratory of Medicinal Chemistry Planning, Department of Pharmaceutical Sciences, Health Sciences Center, Federal University of Pernambuco, Recife, PE, Brazil.,Laboratory of Medicinal Chemistry Planning, Department of Pharmaceutical Sciences, Health Sciences Center, Federal University of Pernambuco, Recife, PE, Brazil
| | - Vanessa Gouveia de Melo Silva
- Laboratory of Medicinal Chemistry Planning, Department of Pharmaceutical Sciences, Health Sciences Center, Federal University of Pernambuco, Recife, PE, Brazil
| | - Janine Siqueira Nunes
- Laboratory of Medicinal Chemistry Planning, Department of Pharmaceutical Sciences, Health Sciences Center, Federal University of Pernambuco, Recife, PE, Brazil
| | | | - Lindomar José Pena
- Laboratory of Virology and Experimental Therapy; Federal University of Pernambuco, Brazil
| | - Ana Cristina Lima Leite
- Laboratory of Medicinal Chemistry Planning, Department of Pharmaceutical Sciences, Health Sciences Center, Federal University of Pernambuco, Recife, PE, Brazil
| |
Collapse
|
9
|
Rosa RB, Ferreira de Castro E, da Silva MV, Paiva Ferreira DC, Jardim ACG, Santos IA, Marinho MDS, Ferreira França FB, Pena LJ. IN VITRO AND IN VIVO MODELS FOR MONKEYPOX. iScience 2022; 26:105702. [PMCID: PMC9712139 DOI: 10.1016/j.isci.2022.105702] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/03/2022] Open
Abstract
The emergence and rapid spread outside of monkeypox virus (MPXV) to nonendemic areas has led to another global health emergency in the midst of the COVID-19 pandemic. The scientific community has sought to rapidly develop in vitro and in vivo models that could be applied in research with MPXV. In vitro models include two-dimensional (2D) cultures of immortalized cell lines or primary cells and three-dimensional (3D) cultures. In vitro models are considered cost-effective and can done in highly controlled conditions, however, they do not always resemble physiological conditions. In this way, several in vivo models are being characterized to meet the growing demand for new studies related to MPXV. In this review, we summarize the main MPXV models that have already been developed and discuss how they can contribute to the advance the understanding of its pathogenesis, replication, and transmission, as well as identifying antivirals to treat infected patients.
Collapse
Affiliation(s)
- Rafael Borges Rosa
- Department of Virology and Experimental Therapy (LAVITE), Aggeu Magalhães Institute (IAM), Oswaldo Cruz Foundation (Fiocruz), Recife 50740-465, Brazil,Rodents Animal Facilities Complex, Federal University of Uberlândia (REBIR-UFU), Uberlândia 38400-902, Brazil
| | - Emilene Ferreira de Castro
- Rodents Animal Facilities Complex, Federal University of Uberlândia (REBIR-UFU), Uberlândia 38400-902, Brazil
| | - Murilo Vieira da Silva
- Rodents Animal Facilities Complex, Federal University of Uberlândia (REBIR-UFU), Uberlândia 38400-902, Brazil
| | | | | | - Igor Andrade Santos
- Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia 38405-302, Brazil
| | | | | | - Lindomar José Pena
- Department of Virology and Experimental Therapy (LAVITE), Aggeu Magalhães Institute (IAM), Oswaldo Cruz Foundation (Fiocruz), Recife 50740-465, Brazil,Corresponding author
| |
Collapse
|
10
|
Melo de Oliveira VN, Flávia do Amaral Moura C, Peixoto ADS, Gonçalves Ferreira VP, Araújo HM, Lapa Montenegro Pimentel LM, Pessoa CDÓ, Nicolete R, Versiani Dos Anjos J, Sharma PP, Rathi B, Pena LJ, Rollin P, Tatibouët A, Nascimento de Oliveira R. Synthesis of alkynylated 1,2,4-oxadiazole/1,2,3-1H-triazole glycoconjugates: Discovering new compounds for use in chemotherapy against lung carcinoma and Mycobacterium tuberculosis. Eur J Med Chem 2021; 220:113472. [PMID: 33940463 DOI: 10.1016/j.ejmech.2021.113472] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2021] [Revised: 04/08/2021] [Accepted: 04/09/2021] [Indexed: 11/25/2022]
Abstract
A total of forty-three compounds were synthesized, including thirty-two new ones. Among those compounds, seventeen were selected and tested on human tumor cell lines: PC-3 (prostate adenocarcinoma), HCT-116 (colorectal tumor), NCIH-460 (lung carcinoma), SKMEL-103 (melanoma) and AGP-01 (gastric tumor). Alkynylated 1,2,4-oxadiazoles 2m, 3g and 3k exhibited antiproliferative activities against NCIH-460 in culture. Alkynylated N-cyclohexyl-1,2,4-oxadiazoles 3a-m and bis-heterocycle glucoglycero-1,2,3-triazole-N-cyclohexyl-1,2,4-oxadiazole derivatives 5a-k and 6-11 were evaluated for their in vitro efficacy towards Mycobacterium tuberculosis (Mtb) H37Ra and H37Rv strains. In general, glycerosugars conjugated to 1,2,4-oxadiazole via a 1,2,3-triazole linkage (5a, 5e, 5j, 5k, and 7) showed in vitro inhibitory activity against Mtb (H37Rv). The largest molecules bis-triazoles 10 and 11, proved inactive against TB. Probably, the absence of the N-cyclohexyl group in compound 8 and 1,2,4-oxadiazole nucleus in compound 9 were responsible for its low activity. Glucoglycero-triazole-oxadiazole derivatives 5e (10 μM) and 7 (23.9 μM) were the most promising antitubercular compounds, showing a better selective index than when tested against RAW 264.7 and HepG2 cells. Vero cell were used to investigate cytotoxicity of compounds 5a, 5h, 5j, 5k, and these compounds showed good cell viability. Further, in silico studies were performed for most active compounds (5e and 7) with potential drug targets, DprE1 and InhA of Mtb to understand possible interactions aided with molecular dynamic simulation (100ns).
Collapse
Affiliation(s)
| | | | | | - Vanessa Pinheiro Gonçalves Ferreira
- Laboratorio de Oncologia Experimental, Nucleo de Pesquisa Em Desenvolvimento de Medicamentos (NPDM), Universidade Federal Do Ceara, Fortaleza, Brazil; Oswaldo Cruz Foundation (Fiocruz), Eusebio, Brazil
| | - Héverton Mendes Araújo
- Laboratorio de Oncologia Experimental, Nucleo de Pesquisa Em Desenvolvimento de Medicamentos (NPDM), Universidade Federal Do Ceara, Fortaleza, Brazil; Oswaldo Cruz Foundation (Fiocruz), Eusebio, Brazil
| | | | - Claudia do Ó Pessoa
- Laboratorio de Oncologia Experimental, Nucleo de Pesquisa Em Desenvolvimento de Medicamentos (NPDM), Universidade Federal Do Ceara, Fortaleza, Brazil
| | - Roberto Nicolete
- Laboratorio de Oncologia Experimental, Nucleo de Pesquisa Em Desenvolvimento de Medicamentos (NPDM), Universidade Federal Do Ceara, Fortaleza, Brazil; Oswaldo Cruz Foundation (Fiocruz), Eusebio, Brazil
| | | | - Prem Prakash Sharma
- Laboratory for Translational Chemistry and Drug Discovery, Department of Chemistry, Hansraj College University Enclave, University of Delhi, Delhi, India
| | - Brijesh Rathi
- Laboratory for Translational Chemistry and Drug Discovery, Department of Chemistry, Hansraj College University Enclave, University of Delhi, Delhi, India
| | - Lindomar José Pena
- Department of Virology, Oswaldo Cruz Foundation, Fiocruz, 50740-465, Recife, PE, Brazil
| | - Patrick Rollin
- Universite D'Orleans et CNRS, ICOA, UMR 7311, BP 6759, F-45067, Orleans, France
| | - Arnaud Tatibouët
- Universite D'Orleans et CNRS, ICOA, UMR 7311, BP 6759, F-45067, Orleans, France
| | | |
Collapse
|
11
|
de Carvalho OV, Rebouças Santos M, Lopes Rangel Fietto J, Pires Moraes M, de Almeida MR, Costa Bressan G, José Pena L, Silva-Júnior A. Multi-targeted gene silencing strategies inhibit replication of Canine morbillivirus. BMC Vet Res 2020; 16:448. [PMID: 33213424 PMCID: PMC7676405 DOI: 10.1186/s12917-020-02671-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2020] [Accepted: 11/06/2020] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Canine morbilivirus (canine distemper virus, CDV) is a highly contagious pathogen associated with high morbidity and mortality in susceptible carnivores. Although there are CDV vaccines available, the disease poses a huge threat to dogs and wildlife hosts due to vaccine failures and lack of effective treatment. Thus, the development of therapeutics is an urgent need to achieve rapid outbreak control and reduce mortality in target species. Gene silencing by RNA interference has emerged as a promising therapeutic approach against different human and animal viruses. In this study, plasmid-based short hairpin RNAs (shRNAs) against three different regions in either CDV nucleoprotein (N), or large polymerase (L) genes and recombinant adenovirus-expressing N-specific multi-shRNAs were generated. Viral cytopathic effect, virus titration, plaque-forming unit reduction, and real-time quantitative RT-PCR analysis were used to check the efficiency of constructs against CDV. RESULTS In CDV-infected VerodogSLAM cells, shRNA-expressing plasmids targeting the N gene markedly inhibited the CDV replication in a dose-dependent manner, with viral genomes and titers being decreased by over 99%. Transfection of plasmid-based shRNAs against the L gene displayed weaker inhibition of viral RNA level and virus yield as compared to CDV N shRNAs. A combination of shRNAs targeting three sites in the N gene considerably reduced CDV RNA and viral titers, but their effect was not synergistic. Recombinant adenovirus-expressing multiple shRNAs against CDV N gene achieved a highly efficient knockdown of CDV N mRNAs and successful inhibition of CDV replication. CONCLUSIONS We found that this strategy had strong silencing effects on CDV replication in vitro. Our findings indicate that the delivery of shRNAs using plasmid or adenovirus vectors potently inhibits CDV replication and provides a basis for the development of therapeutic strategies for clinical trials.
Collapse
Affiliation(s)
- Otávio Valério de Carvalho
- Laboratory of Immunobiological and Animal Virology, Department of Veterinary Medicine, Federal University of Viçosa, Av. Peter Henry Rolfs, s/n, Viçosa, MG, 36570-000, Brazil
- Department of Virology and Experimental Therapy, Oswaldo Cruz Foundation (FIOCRUZ), Aggeu Magalhães Research Center, Av. Moraes Rego, s/n, Campus UFPE, Cidade Universitária, Recife, PE, 50670-420, Brazil
| | - Marcus Rebouças Santos
- Laboratory of Immunobiological and Animal Virology, Department of Veterinary Medicine, Federal University of Viçosa, Av. Peter Henry Rolfs, s/n, Viçosa, MG, 36570-000, Brazil
| | - Juliana Lopes Rangel Fietto
- Department of Biochemistry and Molecular Biology, Federal University of Viçosa, Av. Peter Henry Rolfs, s/n, Viçosa, MG, 36570-000, Brazil
| | - Mauro Pires Moraes
- Laboratory of Immunobiological and Animal Virology, Department of Veterinary Medicine, Federal University of Viçosa, Av. Peter Henry Rolfs, s/n, Viçosa, MG, 36570-000, Brazil
| | - Márcia Rogéria de Almeida
- Department of Biochemistry and Molecular Biology, Federal University of Viçosa, Av. Peter Henry Rolfs, s/n, Viçosa, MG, 36570-000, Brazil
| | - Gustavo Costa Bressan
- Department of Biochemistry and Molecular Biology, Federal University of Viçosa, Av. Peter Henry Rolfs, s/n, Viçosa, MG, 36570-000, Brazil
| | - Lindomar José Pena
- Department of Virology and Experimental Therapy, Oswaldo Cruz Foundation (FIOCRUZ), Aggeu Magalhães Research Center, Av. Moraes Rego, s/n, Campus UFPE, Cidade Universitária, Recife, PE, 50670-420, Brazil.
| | - Abelardo Silva-Júnior
- Department of Virology and Experimental Therapy, Oswaldo Cruz Foundation (FIOCRUZ), Aggeu Magalhães Research Center, Av. Moraes Rego, s/n, Campus UFPE, Cidade Universitária, Recife, PE, 50670-420, Brazil.
| |
Collapse
|
12
|
Matthews Q, da Silva SJR, Norouzi M, Pena LJ, Pardee K. Adaptive, diverse and de-centralized diagnostics are key to the future of outbreak response. BMC Biol 2020; 18:153. [PMID: 33115440 PMCID: PMC7592445 DOI: 10.1186/s12915-020-00891-4] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2020] [Accepted: 10/08/2020] [Indexed: 12/24/2022] Open
Abstract
The global spread of SARS-CoV-2 has shaken our health care and economic systems, prompting re-evaluation of long-held views on how best to deliver care. This is especially the case for our global diagnostic strategy. While current laboratory-based centralized RT-qPCR will continue to serve as a gold standard diagnostic into the foreseeable future, the shortcomings of our dependence on this method have been laid bare. It is now clear that a robust diagnostics pandemic response strategy, like any disaster planning, must include adaptive, diverse and de-centralized solutions. Here we look at how the COVID-19 pandemic, and previous outbreaks, have set the stage for a new innovative phase in diagnostics and a re-thinking of pandemic preparedness.
Collapse
Affiliation(s)
- Quinn Matthews
- Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
| | | | - Masoud Norouzi
- Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
| | - Lindomar José Pena
- Department of Virology, Aggeu Magalhaes Institute (IAM), Oswaldo Cruz Foundation (Fiocruz), Recife, Pernambuco, Brazil
| | - Keith Pardee
- Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada. .,Department of Mechanical and Industrial Engineering, University of Toronto, Toronto, ON, Canada.
| |
Collapse
|
13
|
Brito Ferreira ML, Militão de Albuquerque MDFP, de Brito CAA, de Oliveira França RF, Porto Moreira ÁJ, de Morais Machado MÍ, da Paz Melo R, Medialdea-Carrera R, Dornelas Mesquita S, Lopes Santos M, Mehta R, Ramos E Silva R, Leonhard SE, Ellul M, Rosala-Hallas A, Burnside G, Turtle L, Griffiths MJ, Jacobs BC, Bhojak M, Willison HJ, Pena LJ, Pardo CA, Ximenes RAA, Martelli CMT, Brown DWG, Cordeiro MT, Lant S, Solomon T. Neurological disease in adults with Zika and chikungunya virus infection in Northeast Brazil: a prospective observational study. Lancet Neurol 2020; 19:826-839. [PMID: 32949543 PMCID: PMC7494308 DOI: 10.1016/s1474-4422(20)30232-5] [Citation(s) in RCA: 63] [Impact Index Per Article: 15.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2020] [Revised: 06/15/2020] [Accepted: 06/24/2020] [Indexed: 01/19/2023]
Abstract
BACKGROUND Since 2015, the arthropod-borne viruses (arboviruses) Zika and chikungunya have spread across the Americas causing outbreaks, accompanied by increases in immune-mediated and infectious neurological disease. The spectrum of neurological manifestations linked to these viruses, and the importance of dual infection, are not known fully. We aimed to investigate whether neurological presentations differed according to the infecting arbovirus, and whether patients with dual infection had a different disease spectrum or severity. METHODS We report a prospective observational study done during epidemics of Zika and chikungunya viruses in Recife, Pernambuco, a dengue-endemic area of Brazil. We recruited adults aged 18 years or older referred to Hospital da Restauração, a secondary-level and tertiary-level hospital, with suspected acute neurological disease and a history of suspected arboviral infection. We looked for evidence of Zika, chikungunya, or dengue infection by viral RNA or specific IgM antibodies in serum or CSF. We grouped patients according to their arbovirus laboratory diagnosis and then compared demographic and clinical characteristics. FINDINGS Between Dec 4, 2014, and Dec 4, 2016, 1410 patients were admitted to the hospital neurology service; 201 (14%) had symptoms consistent with arbovirus infection and sufficient samples for diagnostic testing and were included in the study. The median age was 48 years (IQR 34-60), and 106 (53%) were women. 148 (74%) of 201 patients had laboratory evidence of arboviral infection. 98 (49%) of them had a single viral infection (41 [20%] had Zika, 55 [27%] had chikungunya, and two [1%] had dengue infection), whereas 50 (25%) had evidence of dual infection, mostly with Zika and chikungunya viruses (46 [23%] patients). Patients positive for arbovirus infection presented with a broad range of CNS and peripheral nervous system (PNS) disease. Chikungunya infection was more often associated with CNS disease (26 [47%] of 55 patients with chikungunya infection vs six [15%] of 41 with Zika infection; p=0·0008), especially myelitis (12 [22%] patients). Zika infection was more often associated with PNS disease (26 [63%] of 41 patients with Zika infection vs nine [16%] of 55 with chikungunya infection; p≤0·0001), particularly Guillain-Barré syndrome (25 [61%] patients). Patients with Guillain-Barré syndrome who had Zika and chikungunya dual infection had more aggressive disease, requiring intensive care support and longer hospital stays, than those with mono-infection (median 24 days [IQR 20-30] vs 17 days [10-20]; p=0·0028). Eight (17%) of 46 patients with Zika and chikungunya dual infection had a stroke or transient ischaemic attack, compared with five (6%) of 96 patients with Zika or chikungunya mono-infection (p=0·047). INTERPRETATION There is a wide and overlapping spectrum of neurological manifestations caused by Zika or chikungunya mono-infection and by dual infections. The possible increased risk of acute cerebrovascular disease in patients with dual infection merits further investigation. FUNDING Fundação do Amparo a Ciência e Tecnologia de Pernambuco (FACEPE), EU's Horizon 2020 research and innovation programme, National Institute for Health Research. TRANSLATIONS For the Portuguese and Spanish translations of the abstract see Supplementary Materials section.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | - Raquel Medialdea-Carrera
- National Institute for Health Research Health Protection Research Unit on Emerging and Zoonotic Infections, Institute of Infection, Veterinary & Ecological Sciences, University of Liverpool, Liverpool, UK
| | | | - Marcela Lopes Santos
- Department of Collective Health, Institute Aggeu Magalhães, Oswaldo Cruz Foundation, Recife, Brazil
| | - Ravi Mehta
- National Institute for Health Research Health Protection Research Unit on Emerging and Zoonotic Infections, Institute of Infection, Veterinary & Ecological Sciences, University of Liverpool, Liverpool, UK
| | | | - Sonja E Leonhard
- Department of Neurology, Erasmus University Medical Center, Rotterdam, Netherlands
| | - Mark Ellul
- National Institute for Health Research Health Protection Research Unit on Emerging and Zoonotic Infections, Institute of Infection, Veterinary & Ecological Sciences, University of Liverpool, Liverpool, UK; The Walton Centre NHS Foundation Trust, Liverpool, UK
| | | | - Girvan Burnside
- Department of Biostatistics, University of Liverpool, Liverpool, UK
| | - Lance Turtle
- National Institute for Health Research Health Protection Research Unit on Emerging and Zoonotic Infections, Institute of Infection, Veterinary & Ecological Sciences, University of Liverpool, Liverpool, UK; Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK
| | - Michael J Griffiths
- National Institute for Health Research Health Protection Research Unit on Emerging and Zoonotic Infections, Institute of Infection, Veterinary & Ecological Sciences, University of Liverpool, Liverpool, UK; Alder Hey Children's NHS Foundation Trust, Liverpool, UK
| | - Bart C Jacobs
- Department of Neurology, Erasmus University Medical Center, Rotterdam, Netherlands; Department of Immunology, Erasmus University Medical Center, Rotterdam, Netherlands
| | | | - Hugh J Willison
- Department of Neurology and Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK
| | - Lindomar José Pena
- Department of Virology, Institute Aggeu Magalhães, Oswaldo Cruz Foundation, Recife, Brazil
| | - Carlos A Pardo
- Department of Neurology, Division of Neuroimmunology and Neuroinfectious Disorders, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Ricardo A A Ximenes
- Department of Tropical Medicine, Federal University of Pernambuco, Recife, Brazil
| | | | - David W G Brown
- Blood Borne Virus Unit, Virus Reference Department, Public Health England, London, England; Flavivirus Reference Laboratory, Evandro Chagas National Infectious Disease Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil
| | - Marli Tenório Cordeiro
- Department of Virology, Institute Aggeu Magalhães, Oswaldo Cruz Foundation, Recife, Brazil
| | - Suzannah Lant
- National Institute for Health Research Health Protection Research Unit on Emerging and Zoonotic Infections, Institute of Infection, Veterinary & Ecological Sciences, University of Liverpool, Liverpool, UK
| | - Tom Solomon
- National Institute for Health Research Health Protection Research Unit on Emerging and Zoonotic Infections, Institute of Infection, Veterinary & Ecological Sciences, University of Liverpool, Liverpool, UK; The Walton Centre NHS Foundation Trust, Liverpool, UK; Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK.
| |
Collapse
|
14
|
Guarines KM, Mendes RPG, Cordeiro MT, Miagostovich MP, Gil LHVG, Green KY, Pena LJ. Absence of norovirus contamination in shellfish harvested and commercialized in the Northeast coast of Brazil. ACTA ACUST UNITED AC 2020; 53:e9529. [PMID: 32965324 PMCID: PMC7510241 DOI: 10.1590/1414-431x20209529] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2020] [Accepted: 07/16/2020] [Indexed: 11/22/2022]
Abstract
Norovirus (NoV) is the main cause of gastroenteritis outbreaks worldwide. Although NoV spreads mainly from person to person, it is estimated that a large proportion of NoV outbreaks are caused by foodborne transmission. Bivalve mollusks are one of the most important foods involved in NoV transmission to humans. Little is known about NoV prevalence in shellfish harvested and commercialized in Brazil. The aim of this study was to map, for the first time, the distribution of NoV contamination in oysters and mussels harvested and commercialized in the coast of Pernambuco state, northeast Brazil. A total of 380 mollusks (260 oysters and 120 mussels) were collected between February and August 2017 either directly from harvesting areas or obtained from beach vendors at 17 sites in Pernambuco. Samples were processed and tested for NoV contamination using a SYBR Green real-time PCR assay. All samples were negative for NoV GI or GII contamination, suggesting a low risk of NoV contamination from this food source during the study period. Additional surveys in different areas of the Brazilian coast are warranted to monitor the risk of NoV infection upon seafood consumption.
Collapse
Affiliation(s)
- K M Guarines
- Departamento de Virologia, Instituto Aggeu Magalhães, Fundação Oswaldo Cruz, Recife, Pernambuco, Brasil
| | - R P G Mendes
- Departamento de Virologia, Instituto Aggeu Magalhães, Fundação Oswaldo Cruz, Recife, Pernambuco, Brasil
| | - M T Cordeiro
- Departamento de Virologia, Instituto Aggeu Magalhães, Fundação Oswaldo Cruz, Recife, Pernambuco, Brasil
| | - M P Miagostovich
- Laboratório de Virologia Comparativa e Ambiental, Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brasil
| | - L H V G Gil
- Departamento de Virologia, Instituto Aggeu Magalhães, Fundação Oswaldo Cruz, Recife, Pernambuco, Brasil
| | - K Y Green
- Caliciviruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
| | - L J Pena
- Departamento de Virologia, Instituto Aggeu Magalhães, Fundação Oswaldo Cruz, Recife, Pernambuco, Brasil
| |
Collapse
|
15
|
Silva SJRD, Magalhães JJFD, Mendes RPG, Pena LJ. Has Zika Virus Established a Sylvatic Cycle in South America? Acta Trop 2020; 209:105525. [PMID: 32447030 DOI: 10.1016/j.actatropica.2020.105525] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2020] [Revised: 04/21/2020] [Accepted: 05/02/2020] [Indexed: 02/05/2023]
Affiliation(s)
- Severino Jefferson Ribeiro da Silva
- Department of Virology, Aggeu Magalhães Institute (IAM), Oswaldo Cruz Foundation (Fiocruz), Avenida Professor Moraes Rego 50670-420, Recife, Pernambuco, Brazil
| | - Jurandy Júnior Ferraz de Magalhães
- Department of Virology, Aggeu Magalhães Institute (IAM), Oswaldo Cruz Foundation (Fiocruz), Avenida Professor Moraes Rego 50670-420, Recife, Pernambuco, Brazil
| | - Renata Pessôa Germano Mendes
- Department of Virology, Aggeu Magalhães Institute (IAM), Oswaldo Cruz Foundation (Fiocruz), Avenida Professor Moraes Rego 50670-420, Recife, Pernambuco, Brazil
| | - Lindomar José Pena
- Department of Virology, Aggeu Magalhães Institute (IAM), Oswaldo Cruz Foundation (Fiocruz), Avenida Professor Moraes Rego 50670-420, Recife, Pernambuco, Brazil.
| |
Collapse
|
16
|
Julia da Silva Pessoa Vieira C, José Ferreira da Silva D, Rigotti Kubiszeski J, Ceschini Machado L, Pena LJ, Vieira de Morais Bronzoni R, da Luz Wallau G. The Emergence of Chikungunya ECSA Lineage in a Mayaro Endemic Region on the Southern Border of the Amazon Forest. Trop Med Infect Dis 2020; 5:E105. [PMID: 32604785 PMCID: PMC7345197 DOI: 10.3390/tropicalmed5020105] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2020] [Revised: 06/17/2020] [Accepted: 06/19/2020] [Indexed: 12/13/2022] Open
Abstract
Anthropic changes on the edges of the tropical forests may facilitate the emergence of new viruses from the sylvatic environment and the simultaneous circulation of sylvatic and urban viruses in the human population. In this study, we investigated the presence of arboviruses (arthropod-borne viruses) in the sera of 354 patients, sampled from February 2014 to October 2018 in Sinop city. We sequenced the complete genomes of one chikungunya virus (CHIKV)-positive and one out of the 33 Mayaro virus (MAYV)-positive samples. The CHIKV genome obtained here belongs to the East/Central/South African (ECSA) genotype and the MAYV genome belongs to the L genotype. These genomes clustered with other viral strains from different Brazilian states, but the CHIKV strain circulating in Sinop did not cluster with other genomes from the Mato Grosso state, suggesting that at least two independent introductions of this virus occurred in Mato Grosso. Interestingly, the arrival of CHIKV in Sinop seems to not have caused a surge in human cases in the following years, as observed in the rest of the state, suggesting that cross immunity from MAYV infection might be protecting the population from CHIKV infection. These findings reinforce the need for continued genomic surveillance in order to evaluate how simultaneously circulating alphaviruses infecting the human population will unfold.
Collapse
Affiliation(s)
- Carla Julia da Silva Pessoa Vieira
- Health Sciences Institute, Federal University of Mato Grosso, Sinop 78550-728, MT, Brazil; (C.J.d.S.P.V.); (D.J.F.d.S.); (J.R.K.); (R.V.d.M.B.)
| | - David José Ferreira da Silva
- Health Sciences Institute, Federal University of Mato Grosso, Sinop 78550-728, MT, Brazil; (C.J.d.S.P.V.); (D.J.F.d.S.); (J.R.K.); (R.V.d.M.B.)
| | - Janaína Rigotti Kubiszeski
- Health Sciences Institute, Federal University of Mato Grosso, Sinop 78550-728, MT, Brazil; (C.J.d.S.P.V.); (D.J.F.d.S.); (J.R.K.); (R.V.d.M.B.)
| | - Laís Ceschini Machado
- Aggeu Magalhães Institute, Oswaldo Cruz Foundation, Recife 50670-420, PE, Brazil; (L.C.M.); (L.J.P.)
| | - Lindomar José Pena
- Aggeu Magalhães Institute, Oswaldo Cruz Foundation, Recife 50670-420, PE, Brazil; (L.C.M.); (L.J.P.)
| | - Roberta Vieira de Morais Bronzoni
- Health Sciences Institute, Federal University of Mato Grosso, Sinop 78550-728, MT, Brazil; (C.J.d.S.P.V.); (D.J.F.d.S.); (J.R.K.); (R.V.d.M.B.)
| | - Gabriel da Luz Wallau
- Aggeu Magalhães Institute, Oswaldo Cruz Foundation, Recife 50670-420, PE, Brazil; (L.C.M.); (L.J.P.)
| |
Collapse
|
17
|
Abreu LS, do Nascimento YM, Costa RDS, Guedes MLS, Souza BNRF, Pena LJ, Costa VCDO, Scotti MT, Braz-Filho R, Barbosa-Filho JM, da Silva MS, Velozo EDS, Tavares JF. Tri- and Diterpenoids from Stillingia loranthacea as Inhibitors of Zika Virus Replication. J Nat Prod 2019; 82:2721-2730. [PMID: 31599155 DOI: 10.1021/acs.jnatprod.9b00251] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
This study represents the first phytochemical analysis of Stillingia loranthacea (S. loranthacea) and describes new terpenoids obtained from the root bark of this species. The fractionation of the hexane extract from the root bark led to the isolation of two new 28-nor-taraxarenes derivatives, loranthones A and B (1 and 2), four new tigliane diterpenes (5-8), three known tigliane diterpenes (9-11), and three known flexibilene diterpenes, tonantzitlolones A-C (12-14). The investigation of these compounds and the use of a molecular networking-based prioritization approach afforded two other new 28-nor-taraxarenes, loranthones C and D (3 and 4). The cytotoxicity of compounds 1, 2, and 5-14 was evaluated against Vero cells, and their 20% cytotoxic concentration (CC20) values varied from 8.7 to 328 μM; antiviral activity was tested against an epidemic Zika virus (ZIKV) strain circulating in Brazil. Six out of 12 compounds (2, 5, 9-11, and 14) exhibited significant antiviral effects against ZIKV. Specifically, compounds 2 and 5 offered the most promise as lead compounds as they had a 1.7 and 1.8 log10 TCID50/mL reduction in ZIKV replication, respectively. Together, the present findings have identified S. loranthacea terpenoids as potent anti-ZIKV inhibitors and pave the way to the development of possible new treatments against this devastating pathogen.
Collapse
Affiliation(s)
- Lucas Silva Abreu
- Institute for Research in Pharmaceuticals and Medications , Federal University of Paraíba , João Pessoa 58051-900 , Brazil
| | - Yuri Mangueira do Nascimento
- Institute for Research in Pharmaceuticals and Medications , Federal University of Paraíba , João Pessoa 58051-900 , Brazil
| | - Rafael Dos Santos Costa
- Research Laboratory in Materia Medica, School of Pharmacy , Federal University of Bahia , Salvador 40170-290 , Brazil
| | | | | | - Lindomar José Pena
- Department of Virology , Oswaldo Cruz Foundation (Fiocruz) , Recife 50740-465 , Brazil
| | | | - Marcus Tullius Scotti
- Institute for Research in Pharmaceuticals and Medications , Federal University of Paraíba , João Pessoa 58051-900 , Brazil
| | - Raimundo Braz-Filho
- Department of Chemistry, Institute of Chemistry , Federal Rural University of Rio de Janeiro , Seropédica 23890-000 , Brazil
| | - José Maria Barbosa-Filho
- Institute for Research in Pharmaceuticals and Medications , Federal University of Paraíba , João Pessoa 58051-900 , Brazil
| | - Marcelo Sobral da Silva
- Institute for Research in Pharmaceuticals and Medications , Federal University of Paraíba , João Pessoa 58051-900 , Brazil
| | - Eudes da Silva Velozo
- Research Laboratory in Materia Medica, School of Pharmacy , Federal University of Bahia , Salvador 40170-290 , Brazil
| | - Josean Fechine Tavares
- Institute for Research in Pharmaceuticals and Medications , Federal University of Paraíba , João Pessoa 58051-900 , Brazil
| |
Collapse
|
18
|
Aguiar DF, Dutra LLA, Dantas WM, Camelo de Carvalho GG, Gonçalves Lemes RP, do Ó Pessoa C, Koscky Paier CR, Barros Araujo PL, Araujo ES, Pena LJ, de Oliveira RN. Synthesis, Antitumor and Cytotoxic Activity of New Adamantyl
O
‐Acylamidoximes and 3‐Aryl‐5‐Adamantane‐1,2,4‐Oxadiazole Derivatives. ChemistrySelect 2019. [DOI: 10.1002/slct.201901285] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Deivson Ferreira Aguiar
- Department of ChemistryFederal Rural University of Pernambuco, UFRPE 52171-900 Recife, PE Brazil
| | | | | | | | | | - Claudia do Ó Pessoa
- Laboratório de Oncologia ExperimentalNúcleo de Pesquisa em Desenvolvimento de Medicamentos (NPDM) 60430-270 Fortaleza, CE Brazil
| | - Carlos Roberto Koscky Paier
- Laboratório de Oncologia ExperimentalNúcleo de Pesquisa em Desenvolvimento de Medicamentos (NPDM) 60430-270 Fortaleza, CE Brazil
| | | | - Elmo Silvano Araujo
- Department of Nuclear EnergyFederal University of Pernambuco, UFPE 50740-545 Recife, PE Brazil
| | - Lindomar José Pena
- Department of VirologyOswaldo Cruz Foundation, Fiocruz 50740-465, Recife, PE Brazil
| | | |
Collapse
|
19
|
Vieira CJDSP, Machado LC, Pena LJ, de Morais Bronzoni RV, Wallau GL. Spread of two Zika virus lineages in Midwest Brazil. Infect Genet Evol 2019; 75:103974. [PMID: 31340185 DOI: 10.1016/j.meegid.2019.103974] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/25/2019] [Revised: 06/26/2019] [Accepted: 07/19/2019] [Indexed: 01/25/2023]
Abstract
Zika virus (ZIKV) has been intensively studied in South America and across the globe since 2015-2016 epidemics. However, in Brazil - the largest and the most affected country in terms of human infection by this virus, most of the viral molecular information is restricted to metropolitan centers distributed along the Brazilian coast and almost no information is known about the virus spread in most difficult access areas such as the Midwest region of the country. Here, we report two ZIKV complete genomes from samples obtained during arboviral surveillance at the Sinop city, southern border of the Amazonian forest, Midwest Brazil in 2015. Our results show that the virus was introduced in this region through two independent introductions: one occurred at the end of 2014, around the period that the virus was already distributed in other regions of the country and abroad, and a second at the end of 2015. Moreover, these genomes were clustered with other viral strains sampled at distant Brazilian states in line with other findings about the rapid spread of the virus throughout the country.
Collapse
Affiliation(s)
| | - Laís Ceschini Machado
- Entomology Department, Aggeu Magalhães Institute, Oswaldo Cruz Foundation, Recife, Pernambuco, Brazil
| | - Lindomar José Pena
- LaVITE - Laboratory of Virology and Experimental Therapy, Aggeu Magalhães Institute, Oswaldo Cruz Foundation, Recife, Pernambuco, Brazil
| | | | - Gabriel Luz Wallau
- Entomology Department, Aggeu Magalhães Institute, Oswaldo Cruz Foundation, Recife, Pernambuco, Brazil.
| |
Collapse
|
20
|
Pena LJ, Miranda Guarines K, Duarte Silva AJ, Sales Leal LR, Mendes Félix D, Silva A, de Oliveira SA, Junqueira Ayres CF, Júnior AS, de Freitas AC. In vitro and in vivo models for studying Zika virus biology. J Gen Virol 2018; 99:1529-1550. [DOI: 10.1099/jgv.0.001153] [Citation(s) in RCA: 30] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Affiliation(s)
- Lindomar José Pena
- 1Department of Virology, Aggeu Magalhaes Institute (IAM), Oswaldo Cruz Foundation (Fiocruz), Recife, Pernambuco, Brazil
| | - Klarissa Miranda Guarines
- 1Department of Virology, Aggeu Magalhaes Institute (IAM), Oswaldo Cruz Foundation (Fiocruz), Recife, Pernambuco, Brazil
| | - Anna Jéssica Duarte Silva
- 2Department of Genetics, Laboratory of Molecular Studies and Experimental Therapy (LEMTE), Center of Biological Sciences, Federal University of Pernambuco (UFPE), Recife, Pernambuco, Brazil
| | - Lígia Rosa Sales Leal
- 2Department of Genetics, Laboratory of Molecular Studies and Experimental Therapy (LEMTE), Center of Biological Sciences, Federal University of Pernambuco (UFPE), Recife, Pernambuco, Brazil
| | - Daniele Mendes Félix
- 1Department of Virology, Aggeu Magalhaes Institute (IAM), Oswaldo Cruz Foundation (Fiocruz), Recife, Pernambuco, Brazil
| | - Adalúcia Silva
- 1Department of Virology, Aggeu Magalhaes Institute (IAM), Oswaldo Cruz Foundation (Fiocruz), Recife, Pernambuco, Brazil
| | - Sheilla Andrade de Oliveira
- 3Department of Immunology, Aggeu Magalhaes Institute (IAM), Oswaldo Cruz Foundation (Fiocruz), Recife, Pernambuco, Brazil
| | | | - Abelardo Silva Júnior
- 5Department of Veterinary Medicine, Federal University of Viçosa (UFV), Viçosa, Minas Gerais, Brazil
| | - Antonio Carlos de Freitas
- 2Department of Genetics, Laboratory of Molecular Studies and Experimental Therapy (LEMTE), Center of Biological Sciences, Federal University of Pernambuco (UFPE), Recife, Pernambuco, Brazil
| |
Collapse
|
21
|
de Carvalho OV, Félix DM, de Oliveira RN, Seabra G, Júnior AS, Pena LJ. Response to 'On the antiviral activity and developmental toxicity of 6-methylmercaptopurine riboside (6MMPr)' and 'Acceleration with the brakes on?'. Int J Antimicrob Agents 2018; 52:515-516. [PMID: 30318058 DOI: 10.1016/j.ijantimicag.2018.06.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2018] [Accepted: 06/30/2018] [Indexed: 11/30/2022]
Affiliation(s)
- Otávio Valério de Carvalho
- Department of Virology, Oswaldo Cruz Foundation (Fiocruz), Avenida Professor Moraes Rego, Recife, Pernambuco, Brazil
| | - Daniele Mendes Félix
- Department of Virology, Oswaldo Cruz Foundation (Fiocruz), Avenida Professor Moraes Rego, Recife, Pernambuco, Brazil
| | | | - Gustavo Seabra
- Department of Fundamental Chemistry, Federal University of Pernambuco (UFPE), Recife, Pernambuco, Brazil
| | - Abelardo Silva Júnior
- Department of Veterinary Medicine, Federal University of Viçosa (UFV), Av. PH Rolfs, s/n, Viçosa, Minas Gerais 36570-900, Brazil.
| | - Lindomar José Pena
- Department of Virology, Oswaldo Cruz Foundation (Fiocruz), Avenida Professor Moraes Rego, Recife, Pernambuco, Brazil.
| |
Collapse
|
22
|
Meneses JDA, Ishigami AC, de Mello LM, de Albuquerque LL, de Brito CAA, Cordeiro MT, Pena LJ. Lessons Learned at the Epicenter of Brazil's Congenital Zika Epidemic: Evidence From 87 Confirmed Cases. Clin Infect Dis 2018; 64:1302-1308. [PMID: 28329257 DOI: 10.1093/cid/cix166] [Citation(s) in RCA: 74] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2016] [Accepted: 02/21/2017] [Indexed: 02/01/2023] Open
Abstract
Congenital Zika virus infection has stimulated great international concern. A prospective case series of 87 infants with laboratory-confirmed congenital Zika syndrome (CZS) at the epicenter of the Brazilian Zika epidemic in Pernambuco state is presented. Mothers were interviewed for symptoms of possible Zika virus (ZIKV) infection during pregnancy, and fetal ultrasounds were obtained. Infant cerebrospinal fluid (CSF) samples were tested for ZIKV-specific antibodies, and sera were screened for other congenital infections. Neuroimaging and ophthalmologic evaluations were also performed. Sixty-six mothers (76%) reported symptoms of ZIKV infection during gestation. Fetal ultrasounds were available from 90% of the mothers, and all demonstrated brain structural abnormalities. All of the CSF samples tested positive for ZIKV immunoglobulin M. The majority of infants (89%) were term; the mean birth weight was 2577 ± 260 g, and the mean head circumference was 28.1 ± 1.8 cm. Severe microcephaly, defined as head circumference 3 SD below the mean for sex and gestational age, was found in 72 (82%) infants. All infants had an abnormal neurological exam, and 18 (20.7%) had arthrogryposis. The main abnormalities detected in computed tomography scans were calcifications (99%), followed by ventricular enlargement (94%), cortical hypogyration (81%), and less commonly, cerebellar hypoplasia (52%). Unilateral diaphragm paralysis was identified in 3 infants. Maternal young age, term infant, small for gestational age, and the presence of ophthalmologic abnormalities were significantly associated with a smaller head circumference Z score. Our findings, based on laboratory-confirmed ZIKV infection, add valuable evidence for the understanding of CZS.
Collapse
Affiliation(s)
| | | | | | | | | | | | - Lindomar José Pena
- Department of Virology, Oswaldo Cruz Foundation (Fiocruz), Recife, Pernambuco, and
| |
Collapse
|
23
|
Brito Ferreira ML, Antunes de Brito CA, Moreira ÁJP, de Morais Machado MÍ, Henriques-Souza A, Cordeiro MT, de Azevedo Marques ET, Pena LJ. Guillain-Barré Syndrome, Acute Disseminated Encephalomyelitis and Encephalitis Associated with Zika Virus Infection in Brazil: Detection of Viral RNA and Isolation of Virus during Late Infection. Am J Trop Med Hyg 2017; 97:1405-1409. [PMID: 29140242 DOI: 10.4269/ajtmh.17-0106] [Citation(s) in RCA: 47] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
Zika virus (ZIKV) emerged in Brazil in 2015, which was followed by an increase of Guillain-Barre Syndrome (GBS) cases. We report the epidemiological, clinical, and laboratory findings of the first six neurological cases associated with ZIKV in Brazil seen in a reference neurology hospital in Pernambuco, Brazil. In all cases, ZIKV was detected in serum and/or cerebrospinal fluid (CSF) samples. In this case series, four cases were defined as GBS, one as acute disseminated encephalomyelitis (ADEM) and the other as encephalitis. ZIKV was detected in all cases by RT-PCR and virus isolation was successful in two patients. The time between ZIKV acute symptoms and the development of neurological manifestations varied from 3 to 13 days and ZIKV was detected between 15 and 34 days after the initial symptoms. Our results highlight the need to include ZIKV as a differential diagnosis for neurological syndromes in countries with circulation of this arbovirus. Because the viremia in these patients appears to persist longer, direct diagnostic techniques such as RT-PCR and viral isolation should be considered even if it is after the acute phase of viral infection.
Collapse
Affiliation(s)
| | | | | | | | | | - Marli Tenório Cordeiro
- Aggeu Magalhães Institute, Oswaldo Cruz Foundation (Fiocruz), Recife, Pernambuco, Brazil
| | | | - Lindomar José Pena
- Aggeu Magalhães Institute, Oswaldo Cruz Foundation (Fiocruz), Recife, Pernambuco, Brazil
| |
Collapse
|
24
|
de Carvalho OV, Félix DM, de Mendonça LR, de Araújo CMCS, de Oliveira Franca RF, Cordeiro MT, Silva Júnior A, Pena LJ. The thiopurine nucleoside analogue 6-methylmercaptopurine riboside (6MMPr) effectively blocks Zika virus replication. Int J Antimicrob Agents 2017; 50:718-725. [PMID: 28803932 DOI: 10.1016/j.ijantimicag.2017.08.016] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2016] [Revised: 07/05/2017] [Accepted: 08/05/2017] [Indexed: 10/19/2022]
Abstract
Since the emergence of Zika virus (ZIKV) in Brazil in 2015, 48 countries and territories in the Americas have confirmed autochthonous cases of disease caused by the virus. ZIKV-associated neurological manifestations and congenital defects make the development of safe and effective antivirals against ZIKV of utmost importance. Here we evaluated the antiviral activity of 6-methylmercaptopurine riboside (6MMPr), a thiopurine nucleoside analogue derived from the prodrug azathioprine, against the epidemic ZIKV strain circulating in Brazil. In all of the assays, an epithelial (Vero) and a human neuronal (SH-SY5Y) cell line were used to evaluate the cytotoxicity and effective concentrations of 6MMPr against ZIKV. Levels of ZIKV-RNA, viral infectious titre and the percentage of infected cells in the presence or absence of 6MMPr were used to determine antiviral efficacy. 6MMPr decreased ZIKV production by >99% in both cell lines in a dose- and time-dependent manner. Interestingly, 6MMPr was 1.6 times less toxic to SH-SY5Y cells compared with Vero cells, presenting a 50% cytotoxic concentrations (CC50) of 460.3 µM and 291 µM, respectively. The selectivity index of 6MMPr for Vero and SH-SY5Y cells was 11.9 and 22.7, respectively, highlighting the safety profile of the drug to neuronal cells. Taken together, these results identify, for the first time, the thiopurine nucleoside analogue 6MMPr as a promising antiviral candidate against ZIKV that warrants further in vivo evaluation.
Collapse
Affiliation(s)
- Otavio Valério de Carvalho
- Department of Virology, Oswaldo Cruz Foundation (Fiocruz), Avenida Professor Moraes Rego, Recife, Pernambuco, Brazil
| | - Daniele Mendes Félix
- Department of Virology, Oswaldo Cruz Foundation (Fiocruz), Avenida Professor Moraes Rego, Recife, Pernambuco, Brazil
| | - Leila Rodrigues de Mendonça
- Department of Virology, Oswaldo Cruz Foundation (Fiocruz), Avenida Professor Moraes Rego, Recife, Pernambuco, Brazil
| | | | | | - Marli Tenório Cordeiro
- Department of Virology, Oswaldo Cruz Foundation (Fiocruz), Avenida Professor Moraes Rego, Recife, Pernambuco, Brazil
| | - Abelardo Silva Júnior
- Department of Veterinary Medicine, Federal University of Viçosa (UFV), Av. PH Rolfs, s/n, Viçosa, Minas Gerais 36570-900, Brazil.
| | - Lindomar José Pena
- Department of Virology, Oswaldo Cruz Foundation (Fiocruz), Avenida Professor Moraes Rego, Recife, Pernambuco, Brazil.
| |
Collapse
|
25
|
de Carvalho OV, Félix DM, de Camargo Tozato C, Fietto JLR, de Almeida MR, Bressan GC, Pena LJ, Silva-Júnior A. 6-methylmercaptopurine riboside, a thiopurine nucleoside with antiviral activity against canine distemper virus in vitro. Virol J 2017. [PMID: 28651549 PMCID: PMC5485505 DOI: 10.1186/s12985-017-0785-6] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Canine distemper (CD) is a widespread infectious disease that can severely impact a variety of species in the order Carnivora, as well as non-carnivore species such as non-human primates. Despite large-scale vaccination campaigns, several fatal outbreaks have been reported in wild and domestic carnivore populations. This, in association with expansion of the disease host range and the development of vaccine-escape strains, has contributed to an increased demand for therapeutic strategies synergizing with vaccine programs for effectively controlling canine distemper. 6-methylmercaptopurine riboside (6MMPr) is a modified thiopurine nucleoside with known antiviral properties against certain RNA viruses. METHODS We tested the inhibitory effects of 6MMPr against a wild-type CDV strain infection in cell culture. We measured infectious particle production and viral RNA levels in treated and untreated CDV-infected cells. Ribavirin (RIB) was used as a positive control. RESULTS Here, we report for the first time the antiviral effects of 6MMPr against canine distemper virus (CDV) in vitro. 6MMPr was able to reduce viral RNA levels and to inhibit the production of infectious CDV particles. The therapeutic selectivity of 6MMPr was approximately six times higher than that of ribavirin. CONCLUSION Our results indicate that 6MMPr has high anti-CDV potential and warrants further testing against other paramyxoviruses, as well as clinical testing of the compound against CDV.
Collapse
Affiliation(s)
- Otávio Valério de Carvalho
- Laboratory of Animal Virology, Department of Veterinary, Universidade Federal of Viçosa, Av. Peter Henry Rolfs, s/n, Viçosa, MG, 36570-000, Brazil.,Laboratory of Virology and Experimental Therapy, Oswaldo Cruz Foundation (FIOCRUZ), Aggeu Magalhães Research Center, Av. Moraes Rego, s/n, Campus UFPE, Cidade Universitária, Recife, PE, 50670-420, Brazil
| | - Daniele Mendes Félix
- Laboratory of Virology and Experimental Therapy, Oswaldo Cruz Foundation (FIOCRUZ), Aggeu Magalhães Research Center, Av. Moraes Rego, s/n, Campus UFPE, Cidade Universitária, Recife, PE, 50670-420, Brazil
| | - Claudia de Camargo Tozato
- Laboratory of Animal and Human Virology, Department of Microbiology and Immunology, Biosciences Institute, Paulista State University, Botucatu, SP, 18618-970, Brazil
| | - Juliana Lopes Rangel Fietto
- Department of Biochemistry and Molecular Biology, Federal University of Viçosa, Av. Peter Henry Rolfs, s/n, Viçosa, MG, 36570-000, Brazil
| | - Márcia Rogéria de Almeida
- Department of Biochemistry and Molecular Biology, Federal University of Viçosa, Av. Peter Henry Rolfs, s/n, Viçosa, MG, 36570-000, Brazil
| | - Gustavo Costa Bressan
- Department of Biochemistry and Molecular Biology, Federal University of Viçosa, Av. Peter Henry Rolfs, s/n, Viçosa, MG, 36570-000, Brazil
| | - Lindomar José Pena
- Laboratory of Virology and Experimental Therapy, Oswaldo Cruz Foundation (FIOCRUZ), Aggeu Magalhães Research Center, Av. Moraes Rego, s/n, Campus UFPE, Cidade Universitária, Recife, PE, 50670-420, Brazil.
| | - Abelardo Silva-Júnior
- Laboratory of Animal Virology, Department of Veterinary, Universidade Federal of Viçosa, Av. Peter Henry Rolfs, s/n, Viçosa, MG, 36570-000, Brazil.
| |
Collapse
|
26
|
Pena LJ, Pena DA, Barrios PR, Dale R, Lamêgo MRDA, Moraes MP. Levantamento soro-epidemiológico da infecção pelo vírus da Anemia Infecciosa Eqüina, da Influenza Eqüina-2 e do Herpesvírus Eqüino-1 em rebanhos do sul do Estado do Pará, Brasil. Braz J Vet Res Anim Sci 2006. [DOI: 10.11606/issn.1678-4456.bjvras.2006.26470] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Os vírus da anemia infecciosa eqüina (EIAV), da influenza eqüina tipo 2 (EIV-2) e o herpesvírus eqüino tipo 1 (EHV-1) são agentes causadores de enfermidades que podem causar graves prejuízos econômicos. O objetivo deste presente estudo foi estimar a freqüência de anticorpos contra o EIAV, EIV-2 e o EHV-1 em rebanhos do sul do Estado do Pará, Brasil. Os anticorpos contra EIAV, EIV-2 e EHV-1 foram detectados pelo teste de IDGA, pelo método de inibição da hemaglutinação e pela técnica de soroneutralização (TCID50 =100), respectivamente. Amostras de sangue de 672, 514 e de 506 equídeos saudáveis e sem histórico de vacinação contra nenhum dos três vírus foram testadas, respectivamente, para EIAV, EIV-2, EHV-1. A seguinte freqüência de soro reativos foi observada: 1,34% para o EIAV; 35,79% para o EIV-2; 45,45% para o EHV-1. Estes resultados indicam que estes agentes estão presentes no rebanho paraense e a adoção de medidas de manejo e profilaxia devem ser priorizadas, garantindo deste modo, a prosperidade da eqüideocultura brasileira.
Collapse
|